Bioleaders Corporation (142760) — Cash Flow Quality Index
Bioleaders Corporation (142760) has a Cash Flow Quality Index of 21.06x as of June 2024. Operating cash flow of ₩19.27 Billion exceeds net income of ₩914.71 Million, indicating high earnings quality where cash backs reported profits. Explore 142760 cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Bioleaders Corporation Cash Flow Quality Index (2023–2023)
Historical Cash Flow Quality Index for Bioleaders Corporation across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Bioleaders Corporation cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Bioleaders Corporation (2023–2023)
Year-by-year earnings quality comparison for Bioleaders Corporation. For live market cap and the full company financial profile, see Bioleaders Corporation market cap and net worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.76x | ₩6.18 Billion | ₩8.07 Billion | — |